Literature DB >> 11846983

The role of IRF-4 in transcriptional regulation.

Sylvia Marecki1, Matthew J Fenton.   

Abstract

Gene expression is a tightly regulated process involving multiple levels of control spanning histone acetylation to protein turnover. One of the first events in this cascade is transcription, which itself is a multistep process involving protein-protein interaction and macromolecular assembly. Here we review the role of the interferon (IFN) regulatory factor (IRF) transcription factor family member IRF-4 in transcriptional regulation. IRF-4 was initially characterized in lymphocytes and was shown to function as both a transcriptional repressor and activator. More recently, IRF-4 expression and function have been reported in macrophages. The ability of IRF-4 to serve as both a transcriptional activator and repressor is determined, in part, by binding to distinct DNA-binding motifs and through interaction with various additional transcription factors, most notably with the Ets family member PU.1. The details governing these functional differences are the focus of this review. Importantly, the role of posttranslational modification and nuclear translocation of IRF-4 in transcriptional regulation are addressed. Several possible paradigms of transcriptional regulation by IRF-4 are proposed, where these paradigms may describe regulatory mechanisms common to many distinct transcription factor families.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846983     DOI: 10.1089/107999002753452737

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  24 in total

1.  Structural Studies of IRF4 Reveal a Flexible Autoinhibitory Region and a Compact Linker Domain.

Authors:  Soumya G Remesh; Vishaka Santosh; Carlos R Escalante
Journal:  J Biol Chem       Date:  2015-09-24       Impact factor: 5.157

2.  IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation.

Authors:  Sandra Bajaña; Kimberly Roach; Sean Turner; Jinny Paul; Susan Kovats
Journal:  J Immunol       Date:  2012-08-29       Impact factor: 5.422

3.  IRF-4 suppresses BCR/ABL transformation of myeloid cells in a DNA binding-independent manner.

Authors:  Seung-Hee Jo; Ruibao Ren
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

Review 4.  Interferon regulatory factor signaling in autoimmune disease.

Authors:  Bharati Matta; Su Song; Dan Li; Betsy J Barnes
Journal:  Cytokine       Date:  2017-03-07       Impact factor: 3.861

5.  Cooperation between deficiencies of IRF-4 and IRF-8 promotes both myeloid and lymphoid tumorigenesis.

Authors:  Seung-Hee Jo; Jonathan H Schatz; Jaime Acquaviva; Harinder Singh; Ruibao Ren
Journal:  Blood       Date:  2010-06-28       Impact factor: 22.113

6.  Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.

Authors:  Claudio Fenizia; Martina Fiocchi; Kathryn Jones; Robyn Washington Parks; Michele Ceribelli; Sebastien A Chevalier; Dustin Edwards; Francis Ruscetti; Cynthia A Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

7.  Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells.

Authors:  Patricia A Valdez; Paul J Vithayathil; Brian M Janelsins; Arthur L Shaffer; Peter R Williamson; Sandip K Datta
Journal:  Immunity       Date:  2012-03-29       Impact factor: 31.745

8.  Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.

Authors:  Carla S Wilson; George S Davidson; Shawn B Martin; Erik Andries; Jeffrey Potter; Richard Harvey; Kerem Ar; Yuexian Xu; Kenneth J Kopecky; Donna P Ankerst; Holly Gundacker; Marilyn L Slovak; Monica Mosquera-Caro; I-Ming Chen; Derek L Stirewalt; Maurice Murphy; Frederick A Schultz; Huining Kang; Xuefei Wang; Jerald P Radich; Frederick R Appelbaum; Susan R Atlas; John Godwin; Cheryl L Willman
Journal:  Blood       Date:  2006-04-04       Impact factor: 22.113

9.  Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4.

Authors:  Esther Carreras; Sean Turner; Mark Barton Frank; Nicholas Knowlton; Jeanette Osban; Michael Centola; Chae Gyu Park; Amie Simmons; José Alberola-Ila; Susan Kovats
Journal:  Blood       Date:  2009-10-30       Impact factor: 22.113

10.  Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes.

Authors:  Dongsheng Xu; Lingjun Zhao; Luis Del Valle; Judith Miklossy; Luwen Zhang
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.